Medical Marijuana Update

Medical Marijuana Update

Medical Marijuana Update

Medical marijuana is safe from the Justice Department for now, governors in New Jersey and Rhode Island make noises about expanding medical marijuana programs, Georgia voters are ready for a full-fledged medical marijuana law, and more.

National

Last Thursday, a House version of a bill aimed at encouraging medical marijuana research was filed. Rep. Rob Bishop (R-UT) filed a House version of a bill aiming at encouraging medical marijuana research. Utah Sen. Orrin Hatch (R) filed the Senate version of the Marijuana Effective Drug Study Act, Senate Bill 1803, in the Senate in September.

Monday, the congressional budget deal retained protections for state-legal medical marijuana. The short-term budget deal approved by Congress retains the Rohrabacher-Blumenauer amendment, which bars the US Justice Department from using its funds to go after medical marijuana patients and operations in states where it is legal. But the continuing budget resolution is only in effect until February 8.

Georgia

Wednesay, a poll found voters were ready for a full-fledged medical marijuana program. A new poll from the Atlanta Journal-Constitution finds that more than three-quarters of those surveyed want to see the state’s limited medical marijuana program expanded. Some 77% said they want greater access to medical marijuana. The poll comes as the legislature considers a measure, House Bill 645, that would allow for medical marijuana dispensaries. The poll also found that support for recreational marijuana was at an all-time high in the state, with 50% saying legalize it.

Indiana

Tuesday, a Senate panel approved a CBD bill. The Senate Corrections and Criminal Law Committee voted 7-2 to approve Senate Bill 52, which would legalize CBD cannabis oil containing less than 0.3% THC. The state already has a CBD law, but that law is limited to epilepsy patients who are registered with the state. This bill would open up CBD use to anyone with a medical conditions.

Thursday, the House called for a study of medical marijuana. The House voted unanimously in support of a resolution calling for a legislative committee to study medical marijuana. If the Senate concurs, a special council comprised of lawmakers from both parties would do the study over the summer.

Kentucky

Wednesday, the House called on the feds to remove roadblocks to medical marijuana research. The House voted 73-5 to approve a resolution calling on the DEA and the FDA to “expedite research on the safety and effectiveness of the use of marijuana for certain health purposes.”

New Jersey

Tuesday, the governor ordered a review of the state’s “constrained” medical marijuana program. Gov. Phil Murphy (D) ordered a 60-day review of the state’s medical marijuana program, which he called “constrained.” He said he would consider allowing home deliveries, allowing purchases beyond the current two-ounce limit, and expanding the number of dispensaries, but he did not mention expanding the list of qualifying medical conditions.

Pennsylvania

Last Wednesday, the state’s first dispensary opened for business. Keystone Canna Remedies had its grand opening in Bethlehem — but it doesn’t actually have any product to sell. The dispensary said it will be doing educational workshops until it gets its first shipments of medical marijuana next month.

Rhode Island

Wednesday, the governor proposed expanding the medical marijuana program. As part of her 2018-2019 budget plan, Gov. Gina Raimondo (D) is proposing quadrupling the number of dispensaries in the state from three to 12, adding “acute pain” to the list of qualifying conditions, and allowing Connecticut and Massachusetts cardholders to buy medical marijuana in the state.

Tennessee

Last Friday, a CBD medical marijuana bill was filed, as 2 Republican lawmakers have filed the Medical Cannabis Only Act, which would legalize the use of cannabis oil products, but not edibles or raw marijuana. The bill is not yet available on the legislative web site.

For extensive information about the medical marijuana debate, presented in a neutral format, visit MedicalMarijuana.ProCon.org.

By Phillip Smith

Paul Ebeling, Editor

 

Permission to Reprint: This article is licensed under a modified Creative Commons Attribution license.
Looking for the easiest way to join the anti-drug war movement? You’ve found it!

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, polymath, excels in diverse fields of knowledge. Pattern Recognition Analyst in Equities, Commodities and Foreign Exchange and author of “The Red Roadmaster’s Technical Report” on the US Major Market Indices™, a highly regarded, weekly financial market letter, he is also a philosopher, issuing insights on a wide range of subjects to a following of over 250,000 cohorts. An international audience of opinion makers, business leaders, and global organizations recognizes Ebeling as an expert.

Latest posts by Paul Ebeling (see all)

You must be logged in to post comments :  
CONNECT WITH